H2DCFDA [4091-99-0]
Cat# HY-D0940-100mg
Size : 100mg
Brand : MedChemExpress
H2DCFDA (DCFH-DA) is a cell-permeable probe used to detect intracellular reactive oxygen species (ROS) (Ex/Em=488/525 nm).
For research use only. We do not sell to patients.
Customer Review
Based on 405 publication(s) in Google Scholar
- •Signal Transduct Target Ther. 2022 Aug 15;7(1):288. [Abstract]
- •Cell. 2021 Jun 24;184(13):3528-3541.e12. [Abstract]
- •Adv Mater. 2025 Jan 10:e2415030. [Abstract]
- •Adv Mater. 2024 Nov 26:e2409176. [Abstract]
- •Adv Mater. 2024 Oct 12:e2411618. [Abstract]
- •Adv Mater. 2023 Sep 5;e2306469. [Abstract]
- •Drug Resist Updat. 2024 Dec 9:79:101183. [Abstract]
- •Cell Mol Immunol. 2023 Aug 9. [Abstract]
- •Drug Resist Updat. 2023 Jul;69:100974.
- •ACS Nano. 2025 Jan 24. [Abstract]
- •ACS Nano. 2025 Jan 25. [Abstract]
- •Adv Sci (Weinh). 2025 Jan 9:e2413833. [Abstract]
- •Adv Sci (Weinh). 2025 Jan 10:e2411911. [Abstract]
- •Adv Sci (Weinh). 2025 Jan 13:e2414307. [Abstract]
- •J Extracell Vesicles. 2024 Sep;13(9):e12505. [Abstract]
- •Bioact Mater. 2024 Jul 9:41:30-45. [Abstract]
- •ACS Nano. 2024 Aug 1. [Abstract]
- •Nat Commun. 2024 Aug 12;15(1):6915. [Abstract]
- •Chem Eng J. 2024 Sep 15.
- •Adv Funct Mater. 2024 May 23.
- •Adv Funct Mater. 2024 May 1.
- •ACS Nano. 2024 Apr 23;18(16):10829-10839. [Abstract]
- •Chem Eng J. 2024 Mar 15, 484, 149308.
- •Adv Funct Mater. 2024 Feb 8.
- •Adv Sci (Weinh). 2023 Oct 30:e2303535. [Abstract]
- •Chem Eng J. 2023 Oct 14, 146421.
- •ACS Nano. 2023 Aug 3. [Abstract]
- •Nat Commun. 2023 Jun 10;14(1):3431. [Abstract]
- •ACS Nano. 2023 Feb 10. [Abstract]
- •Bioact Mater. 2023, 24: 477-496.
- •Sci Bull. 2022 Dec 30;S2095-9273(22)00609-0.
- •Nano Energy. 2022: 108002.
- •ACS Nano. 2022 Oct 11. [Abstract]
- •Adv Sci (Weinh). 2022 Mar 10;e2103317. [Abstract]
- •ACS Nano. 2021 Oct 26;15(10):16286-16297. [Abstract]
- •Bioactive Materials. 2021 Sep 4;10:131-144. [Abstract]
- •Bone Res. 2025 Jan 16;13(1):9. [Abstract]
- •Redox Biol. 2024 Dec 25:79:103482. [Abstract]
- •J Exp Clin Cancer Res. 2024 Dec 26;43(1):330. [Abstract]
- •J Nanobiotechnology. 2024 Nov 30;22(1):744. [Abstract]
- •Acta Pharm Sin B. 2024 Oct 22.
- •J Immunother Cancer. 2024 Nov 17;12(11):e009949. [Abstract]
- •J Nanobiotechnology. 2024 Sep 30;22(1):593. [Abstract]
- •J Control Release. 2024 Sep 13:375:269-284. [Abstract]
- •J Control Release. 2024 Sep 17:375:316-330. [Abstract]
- •Asian J Pharm Sci. 2024 Aug 19.
- •J Hazard Mater. 2024 Jul 31:477:135391. [Abstract]
- •Small. 2024 Jul 2:e2402141. [Abstract]
- •Theranostics. 2024 Jun 17;14(9):3719-3738. [Abstract]
- •J Control Release. 2024 Jun 28:372:551-570. [Abstract]
- •J Control Release. 2024 Jun 10:371:470-483. [Abstract]
- •Redox Biol. 2024 May 23:73:103207. [Abstract]
- •Biomaterials. 2024 Feb 2:306:122497. [Abstract]
- •Redox Biol. 2023 Sep 28:67:102896. [Abstract]
- •J Integr Plant Biol. 2023 Sep 12. [Abstract]
- •J Control Release. 2023 Jul;359:415-427. [Abstract]
- •Biomater Res. 2023 Jul 1;27(1):63. [Abstract]
- •Biomaterials. 2023 Mar 1;296:122074. [Abstract]
- •Proc Natl Acad Sci U S A. 2022 Aug 9;119(32):e2209904119. [Abstract]
- •J Control Release. 2023 Feb 2;355:68-84. [Abstract]
- •Int J Antimicrob Agents. 2023 Jan 11;106709. [Abstract]
- •Biomaterials. 2022: 121936.
- •Redox Biol. 2022: 102588.
- •Biomater Res. 2022 Dec 2;26(1):71. [Abstract]
- •Biomaterials. 2022 Sep 30;290:121842. [Abstract]
- •J Control Release. 2022 Oct 10;351:860-871. [Abstract]
- •J Hazard Mater. 2022 Oct 5;439:129502. [Abstract]
- •J Control Release. 2022 Aug 23;S0168-3659(22)00544-2. [Abstract]
- •Acta Pharm Sin B. 16 July 2022.
- •Biomaterials. 2022 Jul 21;287:121688. [Abstract]
- •Small. 2022 Jul;18(30):e2202002. [Abstract]
- •Biomaterials. 2022 May;284:121513. [Abstract]
- •Small. 2022 May 12;e2201625. [Abstract]
- •Redox Biol. 2022 May 10;53:102323. [Abstract]
- •Biomaterials. 2022 Apr;283:121437. [Abstract]
- •J Hazard Mater. 2022 May 15;430:128436. [Abstract]
- •Small. 2021 Aug;17(32):e2101368. [Abstract]
- •Biomaterials. 2021 Oct;277:121103. [Abstract]
- •J Hazard Mater. 2022 Jan 15;422:126850. [Abstract]
- •J Hazard Mater. 2021 Oct 5;419:126494. [Abstract]
- •Redox Biol. 2021 Jul;43:101994. [Abstract]
- •Redox Biol. 2021, 101984.
- •Acta Pharm Sin B. 2021 Nov;11(11):3553-3566. [Abstract]
- •J Hazard Mater. 2021 Mar 15;406:124306. [Abstract]
- •Cell Death Dis. 2020 Apr 6;11(4):219. [Abstract]
- •Adv Healthc Mater. 2024 Nov 2:e2402827. [Abstract]
- •Cell Death Dis. 2024 Nov 12;15(11):820. [Abstract]
- •MedComm (2020). 2024 Nov 9;5(11):e756. [Abstract]
- •Food Chem. 2024 Sep 30;464(Pt 1):141470. [Abstract]
- •Adv Healthc Mater. 2024 Sep 5:e2402357. [Abstract]
- •ACS Appl Mater Interfaces. 2024 Sep 19. [Abstract]
- •Int J Biol Macromol. 2024 Sep 18:135743. [Abstract]
- •Int J Biol Sci. 2024 Aug 19;20(11):4476-4495. [Abstract]
- •Mater Today Bio. 2024 Oct.
- •Acta Biomater. 2024 Jun 22.
- •Cell Commun Signal. 2024 Jun 7;22(1):315. [Abstract]
- •Int J Biol Macromol. 2024 Apr 24:131795. [Abstract]
- •Cell Death Dis. 2024 Feb 10;15(2):126. [Abstract]
- •Mol Metab. 2024 Jan 4:101871. [Abstract]
- •Sci Total Environ. 2023 Nov 28:168916. [Abstract]
- •Int J Biol Macromol. 2023 Oct 5;253(Pt 5):127256. [Abstract]
- •Cell Rep. 2023 Sep 26;42(10):113179. [Abstract]
- •Cell Prolif. 2023 Aug 8;e13535. [Abstract]
- •J Colloid Interface Sci. 2023 May 21.
- •Acta Biomater. 2023 May 6;S1742-7061(23)00249-0. [Abstract]
- •Acta Pharmacol Sin. 2023 May 16;1-11. [Abstract]
- •J Colloid Interface Sci. 2023 Mar 2;640:521-539. [Abstract]
- •Int J Biol Sci. 2023 Mar; 19(6):1831-1845.
- •Cell Prolif. 2023 Mar 20;e13443. [Abstract]
- •Mater Design. 2023 Apr.
- •Curr Opin Food Sci. 2023 Feb.
- •Acta Biomater. 2023 Feb 21;S1742-7061(23)00105-8. [Abstract]
- •Chemosphere. 2023 Feb 21;138209. [Abstract]
- •Int J Biol Macromol. 2023 Feb 23;123816. [Abstract]
- •Acta Biomater. 2023 Jan 31;S1742-7061(23)00060-0. [Abstract]
- •Acta Pharmacol Sin. 2022 Nov 8. [Abstract]
- •Adv Healthc Mater. 2022 Oct 27;e2202009. [Abstract]
- •J Neuroinflammation. 2022 Oct 26;19(1):261. [Abstract]
- •Acta Pharmacol Sin. 2022 Oct 25. [Abstract]
- •Acta Biomater. 2022 Sep 12;S1742-7061(22)00570-0. [Abstract]
- •Acta Biomater. 2022 Sep 13;S1742-7061(22)00578-5. [Abstract]
- •Acta Biomater. 2022 Sep 6;S1742-7061(22)00556-6. [Abstract]
- •Adv Healthc Mater. 2022 Aug 1;e2200776. [Abstract]
- •Chemosphere. 15 July 2022, 135680.
- •J Colloid Interface Sci. 23 June 2022.
- •Eur J Nucl Med Mol Imaging. 2022 May 10. [Abstract]
- •Environ Pollut. 2022 Jul 1;304:119178. [Abstract]
- •Int J Biol Macromol. 2022 May 15;207:771-783. [Abstract]
- •Sci Total Environ. 2022 Jan 27;153374. [Abstract]
- •J Colloid Interface Sci. 3 December 2021.
- •Adv Healthc Mater. 2022 Feb;11(3):e2102135. [Abstract]
- •ACS Appl Mater Interfaces. 2021 Nov 11. [Abstract]
- •Curr Biol. 2021 May 18;S0960-9822(21)00607-2. [Abstract]
- •Cell Death Dis. 2020 Nov 17;11(11):988. [Abstract]
- •Cell Death Dis. 2020 Oct 31;11(10):938. [Abstract]
- •ACS Appl Mater Interfaces. 2020 Jul 8;12(27):30145-30154. [Abstract]
- •ACS Appl Mater Interfaces. 2020 Mar 18;12(11):13360-13370. [Abstract]
- •Chemosphere. 2020 Jun;249:126039. [Abstract]
- •Sci Total Environ. 2020 Feb 10;703:135015. [Abstract]
- •Acta Biomater. 2019 Sep 15;96:468-479. [Abstract]
- •ACS Appl Mater Interfaces. 2019 Sep 25;11(38):34663-34675. [Abstract]
- •Cell Rep. 2019 Jul 2;28(1):78-90.e6. [Abstract]
- •Int J Nanomedicine. 2024 Dec 24:19:13875-13900. [Abstract]
- •J Anim Sci Biotechnol. 2024 Dec 2;15(1):159. [Abstract]
- •Antioxidants. 2024 Dec 9;13(12):1499. [Abstract]
- •Phytomedicine. 2024 Oct 11:135:156143. [Abstract]
- •Life Sci. 2024 Oct 9:123128. [Abstract]
- •Life Sci. 2024 Oct 16:123131. [Abstract]
- •Eur J Med Chem. 2024 Oct 5:276:116701. [Abstract]
- •Biomed Pharmacother. 2024 Jun 7:176:116855. [Abstract]
- •Phytother Res. 2024 Jun 4. [Abstract]
- •Biomed Pharmacother. 2024 May 21:175:116784. [Abstract]
- •J Environ Sci. 2024 May 22.
- •Microbiol Res. 2024 Apr 6:284:127711. [Abstract]
- •Biochim Biophys Acta Mol Basis Dis. 2024 May 6:167220. [Abstract]
- •Antioxidants (Basel). 2024 Apr 16;13(4):468.
- •Int J Nanomedicine. 2024 Mar 5.
- •Environ Technol Innov. 2024 May, 34, 103596.
- •J Transl Med. 2024 Feb 15;22(1):155. [Abstract]
- •Free Radic Biol Med. 2024 Jan 6:S0891-5849(24)00007-8. [Abstract]
- •Bioeng Transl Med. 2023 Nov 8.
- •J Agric Food Chem. 2023 Nov 3. [Abstract]
- •Biomed Pharmacother. 2023 Oct 11:168:115665. [Abstract]
- •Antioxidants (Basel). 2023 Oct 26, 12(11), 1917.
- •Free Radic Biol Med. 2023 Sep 17;S0891-5849(23)00641-X. [Abstract]
- •Free Radic Biol Med. 2023 Jul 27;S0891-5849(23)00548-8. [Abstract]
- •Free Radic Biol Med. 2023 Aug, 139, 108897.
- •Life Sci. 2023 Jun 6;121839. [Abstract]
- •Eur J Med Chem. 2023 Apr 28;255:115417. [Abstract]
- •J Transl Med. 2023 Mar 25;21(1):218. [Abstract]
- •Antioxidants (Basel). 2023, 12(2), 301.
- •Cell Biosci. 2022 Nov 4;12(1):180. [Abstract]
- •Free Radic Biol Med. 2022 Nov 17;193(Pt 2):795-807. [Abstract]
- •Phytomedicine. 2022 Mar 2;99:154027. [Abstract]
- •OncoImmunology. 2022 Feb 1;11(1):2032918. [Abstract]
- •Free Radic Biol Med. 20 November 2021.
- •Anal Chem. 2021 Oct 19;93(41):13823-13834. [Abstract]
- •Biomed Pharmacother. October 2021, 112046.
- •Phytomedicine. 2021, 153657.
- •Front Immunol. 02 June 2021.
- •Plant Physiol. 2021 Jun 11;186(2):1302-1317. [Abstract]
- •Biomacromolecules. 2021 May 23. [Abstract]
- •Biochim Biophys Acta Mol Basis Dis. 2021 May 18;1867(9):166171. [Abstract]
- •Biomed Pharmacother. 2021, 111568.
- •Cell Mol Gastroenterol Hepatol. 2021 Jan 19;S2352-345X(21)00013-8. [Abstract]
- •Acta Physiol. 2021 Mar;231(3):e13586. [Abstract]
- •Biomed Pharmacother. 2020 Oct;130:110580. [Abstract]
- •J Agric Food Chem. 2020 Jan 8;68(1):213-224. [Abstract]
- •J Agric Food Chem. 2019 Oct 16;67(41):11518-11526. [Abstract]
- •Commun Biol. 2025 Jan 10;8(1):36. [Abstract]
- •Mol Med. 2024 Nov 6;30(1):203. [Abstract]
- •Inflammation. 2024 Dec 27. [Abstract]
- •Immunol Res. 2025 Jan 17;73(1):37. [Abstract]
- •Mol Cell Biochem. 2024 Dec 4. [Abstract]
- •Eur J Med Res. 2025 Jan 17;30(1):35. [Abstract]
- •Mol Med. 2024 Dec 19;30(1):245. [Abstract]
- •J Cell Mol Med. 2024 Dec;28(23):e70278. [Abstract]
- •Food Biosci. 2024 Nov 28.
- •Int Immunopharmacol. 2024 Oct 16;143(Pt 2):113328. [Abstract]
- •Nanomaterials. 2024 Sep 29;14(19):1572. [Abstract]
- •Exp Neurol. 2024 Sep 30:114983. [Abstract]
- •Sci Rep. 2024 Oct 16;14(1):24223. [Abstract]
- •J Mol Cell Cardiol. 2024 Sep 6:S0022-2828(24)00143-3. [Abstract]
- •Toxicology. 2024 Sep 20:153956. [Abstract]
- •Int J Mol Sci. 2024 Jul 28.
- •J Funct Foods. 2024 Oct.
- •Food Biosci. 2024 Oct.
- •Clin Chim Acta. 2024 Aug 16:119930. [Abstract]
- •Sci Rep. 2024 Sep 2;14(1):20388. [Abstract]
- •Molecules. 2024 Aug 26;29(17):4041. [Abstract]
- •Commun Biol. 2024 Jul 20;7(1):887. [Abstract]
- •Int Immunopharmacol. 2024 Jul 17:139:112688. [Abstract]
- •Front Chem. 2024 Jun 24:12:1417715. [Abstract]
- •Cell Signal. 2024 Jul 3:111285. [Abstract]
- •Pharmaceuticals (Basel). 2024 May 24;17(6):678. [Abstract]
- •Nutrients. 2024 May 26.
- •Am J Cancer Res. 2024 May 15;14(5):2088-2102. [Abstract]
- •Mol Pharm. 2024 Jun 10. [Abstract]
- •mSphere. 2024 Jun 18:e0037724. [Abstract]
- •Macromol Biosci. 2024 May 29:e2400050. [Abstract]
- •Int J Mol Sci. 2024 May 16;25(10):5424. [Abstract]
- •Colloids Surf B Biointerfaces. 2024 Jun:238:113887. [Abstract]
- •J Biol Chem. 2024 Apr 25:107320. [Abstract]
- •Chem Biol Interact. 2024 Mar 12:110956. [Abstract]
- •J Neurochem. 2024 Feb 12. [Abstract]
- •J Neurochem. 2024 Feb 21. [Abstract]
- •J Funct Foods. 2024 Jan, 112, 105989.
- •Int J Mol Sci. 2024 Jan 23, 25(3), 1366.
- •Int J Mol Sci. 2023 Dec 21, 25(1), 134.
- •Int J Food Microbiol. 2023 Dec 26, 110551.
- •Eur J Pharmacol. 2023 Dec 12:176253. [Abstract]
- •Saudi Pharm J. 2024 Jan, 32(1), 101897.
- •Radiother Oncol. 2023 Nov 23:110028. [Abstract]
- •Environ Toxicol. 2023 Nov 17. [Abstract]
- •J Sci Food Agric. 2023 Oct 18. [Abstract]
- •Int J Mol Sci. 2023 Sep 12, 24(18), 14010.
- •Ann N Y Acad Sci. 2023 Sep 2. [Abstract]
- •Mol Neurobiol. 2023 Sep 11. [Abstract]
- •J Mol Cell Cardiol. 2023 Sep 7;183:54-66. [Abstract]
- •Int J Pharm X. 2023 Sep 12, 100211.
- •Eur J Med Res. 2023 Sep 25;28(1):371. [Abstract]
- •Eur J Med Res. 2023 Sep 7;28(1):323. [Abstract]
- •Appl Microbiol Biotechnol. 2023 Aug 11. [Abstract]
- •Int J Mol Med. 2023 Jul 17.
- •Aquaculture. 2023 Nov 15, 576, 739866.
- •Food Control. 2023 Jun 13, 109936.
- •Chem Biol Interact. 2023 May 31;110588. [Abstract]
- •Chem Biol Interact. 2023 Jun 13, 110604.
- •iScience. 2023 Mar.
- •Environ Sci Pollut Res Int. 2023 Feb 25. [Abstract]
- •Front Plant Sci. 2023 Feb 16.
- •FASEB J. 2023 Mar;37(3):e22794. [Abstract]
- •Int J Mol Sci. 2022 Dec 16;23(24):16057. [Abstract]
- •Int Immunopharmacol. 2022 Dec 15;114:109493. [Abstract]
- •Food Biosci. 2022: 102315.
- •J Inflamm. 2022 Nov 30;19(1):24. [Abstract]
- •Colloids Surf B Biointerfaces. 25 October 2022, 112971.
- •Cancer Cell Int. 2022 Oct 7;22(1):304. [Abstract]
- •Transl Oncol. 2022 Sep 21;26:101544. [Abstract]
- •Front Pharmacol. 22 July 2022.
- •J Immunol Res. 17 Jun 2022.
- •Int J Mol Sci. 2022 May 5;23(9):5172. [Abstract]
- •Int J Mol Med. 2022 Jul;50(1):89. [Abstract]
- •Bioengineered. 2022 Apr;13(4):9145-9155. [Abstract]
- •Int J Mol Sci. 2022 Mar 25;23(7):3576. [Abstract]
- •Front Pharmacol. 2022 Feb 15;13:830328. [Abstract]
- •Mol Pharm. 2022 Feb 11. [Abstract]
- •Bioengineered. 2022 Jan;13(1):1436-1446. [Abstract]
- •Bioengineered. 2022 Jan;13(1):1518-1529. [Abstract]
- •Int Immunopharmacol. 2021 Dec 20;108361. [Abstract]
- •Bioengineered. 2021 Nov 30. [Abstract]
- •FEBS J. 2021 Nov 6. [Abstract]
- •Aquat Toxicol. 11 November 2021, 106022.
- •ACS Appl Bio Mater. September 24, 2021.
- •Front Plant Sci. 23 July 2021.
- •Stem Cells Int. 2021 Aug 27;2021:5555590. [Abstract]
- •Front Microbiol. 2021 Mar 30;12:618476. [Abstract]
- •Aquaculture. 2021, 736978.
- •Environ Microbiol. 2020 Dec 23.
- •Nanotoxicology. 2020 Oct;14(8):1137-1155. [Abstract]
- •Aquaculture. 2020 Jul.
- •Aging (Albany NY). 2020 Jun 11;12(11):11116-11138. [Abstract]
- •Molecules. 2020 Feb 14;25(4):836. [Abstract]
- •Planta. 2020 Feb 19;251(3):69. [Abstract]
- •Cell Cycle. 2020 Feb;19(3):339-353. [Abstract]
- •J Cell Mol Med. 2020 Jan;24(2):1599-1613. [Abstract]
- •Food Chem Toxicol. 2019 Oct;132:110655. [Abstract]
- •Int J Mol Sci. 2019 Feb 18;20(4). pii: E880. [Abstract]
- •Virol Sin. 2018 Oct;33(5):418-428. [Abstract]
- •J Neurooncol. 2025 Jan 3. [Abstract]
- •Redox Rep. 2025 Dec;30(1):2454892. [Abstract]
- •AMB Express. 2024 Dec 24;14(1):141. [Abstract]
- •Naunyn Schmiedebergs Arch Pharmacol. 2024 Dec 21. [Abstract]
- •Reprod Sci. 2024 Dec 5. [Abstract]
- •Leuk Lymphoma. 2024 Nov 11:1-12. [Abstract]
- •Theriogenology. 2025 Jan 15.
- •J Solgel Sci Technol. 2024 Oct 22.
- •J Biomater Sci Polym Ed. 2024 Sep 19:1-25. [Abstract]
- •FEBS Lett. 2024 Sep 3. [Abstract]
- •FEBS Lett. 2024 Sep 12. [Abstract]
- •3 Biotech. 2024 Sep;14(9):216. [Abstract]
- •Int J Rheum Dis. 2024 Aug;27(8):e15297. [Abstract]
- •Microbiol Spectr. 2024 Aug 20:e0117224. [Abstract]
- •J Dairy Sci. 2024 Jul 25:S0022-0302(24)01034-8. [Abstract]
- •J Comput Aided Mol Des. 2024 Aug 10;38(1):28. [Abstract]
- •Brain Res. 2024 Jul 6:149116. [Abstract]
- •Naunyn Schmiedebergs Arch Pharmacol. 2024 Jun 4. [Abstract]
- •PeerJ. 2024 Apr 25:12:e16875. [Abstract]
- •Brain Res. 2023 Dec 16:1825:148724. [Abstract]
- •Exp Gerontol. 2023 Sep 29:182:112299. [Abstract]
- •PLoS One. 2023 Oct 12;18(10):e0292124. [Abstract]
- •Immun Inflamm Dis. 2023 Oct 3.
- •Brain Res. 2023 Oct 6:148607. [Abstract]
- •Exp Ther Med. 2023 Sep 1.
- •Infect Drug Resist. 2023 Jun 27;16:4147-4158. [Abstract]
- •Biol Reprod. 2023 Jul 4;ioad068. [Abstract]
- •Pathol Res Pract. 2023 Jun 28;248:154646. [Abstract]
- •Toxicol In Vitro. 2023 Jun 5;105626. [Abstract]
- •Reprod Biomed Online. 2023 May 9.
- •BMC Gastroenterol. 2023 Apr 6;23(1):114. [Abstract]
- •Plasma Process Polym. 2023 Feb 26.
- •Toxicol In Vitro. 2023 Feb 3;89:105566. [Abstract]
- •Biochem Bioph Res Co. 2022.
- •Pharm Biol. 2022 Dec;60(1):1884-1898. [Abstract]
- •Plasma Process Polym. 11 September 2022.
- •Front Biosci (Landmark Ed). 2022, 27(9), 260.
- •J Environ Sci Health A Tox Hazard Subst Environ Eng. 2022 Jul 19;1-8. [Abstract]
- •Oncol Lett. August 25, 2022.
- •Exp Cell Res. 2022 May 29;417(2):113229. [Abstract]
- •J Surg Res. 2022 Aug;276:379-393. [Abstract]
- •Exp Ther Med. December 17, 2021.
- •Mol Immunol. 19 November 2021.
- •Nanotechnology. 2021 Nov 8. [Abstract]
- •Int J Photoenergy. 09 Nov 2021.
- •Photodiagnosis Photodyn Ther. 2021 Oct 7;102572. [Abstract]
- •Anim Cells Syst. 17 Oct 2021.
- •J Food Sci. 2021 Sep 7. [Abstract]
- •J Med Biochem. 40: 1-9, 2021.
- •Genes Genomics. 2021 Aug 16.. [Abstract]
- •Hum Exp Toxicol. 2021 Dec;40(12):2145-2155. [Abstract]
- •Neurologia. 2021 Mar 11;S0213-4853(21)00022-0. [Abstract]
- •Hum Exp Toxicol. 2021 Jan 29;960327121989416. [Abstract]
- •Int J Med Sci. 2020 Sep 28;17(17):2763-2772. [Abstract]
- •Mol Med Rep. 2020 Sep;22(3):2424-2432. [Abstract]
- •Future Microbiol. 2019 Dec;14:1545-1557. [Abstract]
- •Mol Med Rep. 2020 Jan;21(1):220-228. [Abstract]
- •J Cancer. 2019 Oct 21;10(26):6557-6569. [Abstract]
- •BMC Cancer. 2019 Oct 7;19(1):934. [Abstract]
- •Biochem Cell Biol. 2020 Apr;98(2):208-218. [Abstract]
- •Korean J Physiol Pharmacol. 2024 Nov 1;28(6):549-558. [Abstract]
- •J Integr Neurosci. 2024 Oct 31;23(11):201. [Abstract]
- •J Asian Nat Prod Res. 2024 Jul 3:1-14. [Abstract]
- •Neurochirurgie. 2023 Mar 13;69(3):101426. [Abstract]
- •Perfusion. 2022 May 1;2676591221097220. [Abstract]
- •Trop J Pharm Res. 2021; 20 (11): 2261-2266.
- •Biol Pharm Bull. 2021 Oct 26. [Abstract]
- •Int Ophthalmol. 2021 Mar 17. [Abstract]
- •Xenobiotica. 2020 Mar;50(3):354-362. [Abstract]
- •bioRxiv. 2024 November 28.
- •bioRxiv. 2024 November 15.
- •Cell Insight. 2024 Jul 16;3(5):100186. [Abstract]
- •SSRN. 2024 May 30.
- •Res Sq. 2024 May 20.
- •SSRN. 2024 Apr 11.
- •Research Square Preprint. 2024 Mar 18.
- •SSRN. 2024 Mar 27.
- •SSRN. 2024 Mar 8.
- •Research Square Preprint. 2023 Oct 19.
- •Tokyo University of Agriculture and Technology. 2022 Sep 14.
- •Research Square Preprint. 2023 Sep 21.
- •Research Square Preprint. 2023 Jun 26.
- •Cancer Pathog Ther. 2023 Mar 7.
- •Research Square Print. 2023 Feb 20.
- •Research Square Print. 2023 Feb 14.
- •Pnas nexus . 2022 Dec 24;2(2):pgac310. [Abstract]
- •Pnas nexus . 2022.
- •Original Article. 2022.
- •Research Square Print. November 4th, 2022.
- •Oxid Med Cell Longev. 22 Nov 2022.
- •Research Square Print. October 5th, 2022.
- •Research Square Print. October 26th, 2022.
- •Research Square Print. 2022 Aug.
- •Research Square Preprint. 2022 Jul.
- •Contrast Media Mol Imaging. 31 Jul 2022.
- •Oxid Med Cell Longev. 2022 May 4;2022:9253916. [Abstract]
- •Chem Rev. June 2022, 100112.
- •Oxid Med Cell Longev. 2022 Mar 28;2022:8979329. [Abstract]
- •Research Square Preprint. 2021 Jul.
- •SSRN. 2021 Apr 13.
- •Research Square Preprint. 2021 Jan.
- •Oxid Med Cell Longev. 2020 Nov 12;2020:8184314. [Abstract]
- •Research Square Preprint. 2020 Jun.
- •Oxid Med Cell Longev. 2019 Jul 24;2019:3527809. [Abstract]
- •Int J Clin Exp Pathol. 2018;11(8):3994-4003
-
H2DCFDA purchased from MedChemExpress. Usage Cited in: Adv Sci (Weinh). 2022 Mar 10;e2103317. [Abstract]
- CLSM images of HUVEC cells using DCFH‐DA (0.5 hours) as the fluorescent probe: Control, H2O2, H2O2+10 µg/mL1 PDA NPs, H2O2+40 µg/mL PDA NPs, H2O2+80 µg/mL PDA NPs.
-
H2DCFDA purchased from MedChemExpress. Usage Cited in: Acta Pharm Sin B. 16 July 2022.
- Treated HL-1 cells are washed three times and incubated with DMEM medium containing H2DCFDA (10 μM; 30 min) at 37 °C. The cells then are washed three times with warm DMEM medium and intracellular ROS production is detected by flow cytometry.
-
H2DCFDA purchased from MedChemExpress. Usage Cited in: Biomaterials. 2022 Jul 21;287:121688. [Abstract]
- CLSM images of 4T1 tumor cells stained with DCFH-DA (15 min) after different treatments.
-
H2DCFDA purchased from MedChemExpress. Usage Cited in: Biomaterials. 2022 May;284:121513. [Abstract]
- DCFH-DA (10 μM; 30 min). The ROS generation in 4T1 cells and NIH-3T3 cells incubated with various formulations for 4 h observed by CLSM.
-
H2DCFDA purchased from MedChemExpress. Usage Cited in: Biomaterials. 2022 Sep 30;290:121842. [Abstract]
- DCFH-DA (10 μM; 30 min) or C11-BODIPY-labeled cells are substantially increased after treatment with 1 μM FeSO4.
-
H2DCFDA purchased from MedChemExpress. Usage Cited in: J Hazard Mater. 2022 Oct 5;439:129502. [Abstract]
- Representative DCFH-DA (10 μM; 30 min) staining images (Green) in PBNs exposed PSNPs and/or LPS in vivo and in vitro.
-
H2DCFDA purchased from MedChemExpress. Usage Cited in: Cell. 2021 Jun 24;184(13):3528-3541.e12. [Abstract]
- Stained protoplasts with H2DCFDA for the detection of ROS production and PI for PM integrity and tracked the process by live-cell imaging.
-
H2DCFDA purchased from MedChemExpress. Usage Cited in: ACS Nano. 2021 Oct 26;15(10):16286-16297. [Abstract]
- CLSM image of 4T1 cells after being treated with MM, MMP, and MMTP; cells are stained with DCFH-DA (20 μM; for 1 h).
-
H2DCFDA purchased from MedChemExpress. Usage Cited in: Biomaterials. 2021 Oct;277:121103. [Abstract]
- In vitro experiments are conducted to measure the cellular ROS levels in A549 cells from different treatments via flow cytometry using fluorescent probe H2DCFDA (5 μM; 30 min) to better understand the potential molecular mechanism of SOD@ARA290-HBc on radiation-induced lung injury. H2DCFDA fluorescence intensity in A549 cells significantly increased after irradiation.
-
H2DCFDA purchased from MedChemExpress. Usage Cited in: Small. 2021 Aug;17(32):e2101368. [Abstract]
- Laser scanning confocal fluorescence microscopy images of HT-1080 cells treated with different nanodrugs for the detection of intracellular lipid peroxidation and total ROS using C11-BODIPY and DCFH-DA (100 nM; 10 min) as the corresponding fluorescence probes.
-
H2DCFDA purchased from MedChemExpress. Usage Cited in: Curr Biol. 2021 May 18;S0960-9822(21)00607-2. [Abstract]
- Co-staining stigmas with H2DCFDA (50 μM; for 1-2 hours) and the cell wall indicator propidium iodide (PI) shows that ROS is located in the cytoplasm of papilla cells, near the periphery of the plasma membrane.